Life Technologies (NASDAQ: LIFE) is a company founded in November 2008 by the $6.7 billion merger of Invitrogen Corporation and Applied Biosystems Inc. The Chairman and CEO, Gregory Lucier, was the chairman of Invitrogen.[1]
The combined companies have historical sales of $3.5 billion, 9,500 employees and more than 3,600 patents and exclusive licenses.[1]
[edit] Previous company
The original Life Technologies, Inc. (LTI) was founded in 1983 by the merger of Bethesda Research Laboratories, Inc. (BRL) and GIBCO Corp., a subsidiary of Dexter Corp.[2] In 2000, it was later bought out by the smaller, cash-rich Invitrogen who gradually discontinued the use of the name Life Technologies.[3]
[edit] References
[edit] External links
